Solace Pharmaceuticals Scientists Uncover Molecule Linked To Pain Sensitivity

BOSTON--(BUSINESS WIRE)--Solace Pharmaceuticals announced today the publication of a paper in the journal Nature Medicine by Co-founder and Scientific Advisory Board Chair, Dr. Clifford Woolf, that represents a major new insight into the molecular mechanisms of chronic pain. An estimated 40 million people in the United States alone, nearly 1 in 5 adults, suffer from chronic pain

MORE ON THIS TOPIC